Histological noninvasive tools define distinct profiles between NAFLD, NASH

Both the fatty liver inhibition of progression algorithm and the steatosis activity and fibrosis scoring system identified distinct clinical and biological profiles of disease severity among patients with suspected nonalcoholic fatty liver disease.“These data help better identify steatohepatitis, defined histologically, as an entity with clinical relevance: a more severe form of NAFLD, associated with a higher prevalence and degree of metabolic comorbidities and associated with an almost exclusive relationship with advanced fibrosis,” Fabio Nascimbeni, MD, PhD, of the UniversityRead More

Share on facebook
Share on twitter
Share on linkedin